LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs

Milad Shirvaliloo1,2

  • 1Infectious & Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, 15731, Iran.

Epigenomics
|February 21, 2023
PubMed

Insights

Smoking-induced H19 long noncoding RNA (lncRNA) may worsen angiogenesis by inactivating specific microRNAs (miRNAs). This disruption is implicated in various cancers where these miRNAs normally regulate blood vessel formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Long noncoding RNAs (lncRNAs) are increasingly recognized as key players in cancer development and progression.
  • Cigarette smoke exposure is a significant risk factor for numerous cancers and can influence gene expression, including lncRNAs.
  • Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis and is tightly regulated by various molecular factors.

Purpose of the Study:

  • To propose a hypothetical model explaining how smoking-induced H19 lncRNA exacerbates angiogenesis.
  • To investigate the role of H19 in targeting and inactivating specific microRNAs (miRNAs) involved in angiogenesis regulation.
  • To highlight the potential implications of this mechanism in various smoking-associated cancers.

Main Methods:

  • This is a perspective article, presenting a hypothetical model based on existing literature.
  • The model focuses on the interaction between H19 lncRNA, specific miRNAs (miR-29, miR-30a, miR-107, miR-140, miR-148b, miR-199a, miR-200), and angiogenesis-related genes.
  • The study reviews the dysregulation of these miRNAs in multiple cancer types.

Main Results:

  • H19 lncRNA, induced by cigarette smoke, targets and inactivates a panel of miRNAs that normally inhibit angiogenesis.
  • These miRNAs regulate key angiogenesis factors including BiP, DLL4, FGF7, HIF1A, HIF1B, HIF2A, PDGFB, PDGFRA, VEGFA, VEGFB, VEGFC, VEGFR1, VEGFR2, and VEGFR3.
  • The dysregulation of these miRNAs by H19 is proposed as a mechanism contributing to enhanced angiogenesis in smokers.

Conclusions:

  • H19 lncRNA plays a critical role in smoking-induced angiogenesis by interfering with miRNA-mediated regulation.
  • The inactivation of angiogenesis-inhibiting miRNAs by H19 represents a potential therapeutic target for smoking-related cancers.
  • Understanding this molecular interplay is crucial for developing novel anti-angiogenic strategies in oncology.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K